Article · 15 Dec 2023
ArticlePublished 31 Oct 2026
Personalized Radiotherapy Strategies and Prognostic Factors in Patients with Soft Tissue Sarcomas: A Retrospective Cohort Study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Soft tissue sarcomas (STS) are rare and biologically heterogeneous malignant mesenchymal tumors characterized by diverse histological subtypes, a high propensity for local recurrence, and the potential for distant metastasis. The present study aimed to evaluate the clinical and morphological characteristics of STS and to identify factors associated with tumor recurrence, metastatic progression, and treatment outcomes. Methods: A retrospective cohort study included 101 consecutive patients with histologically confirmed STS treated at the Republican Specialized Scientific- Practical Medical Center of Oncology and Radiology (Tashkent, Uzbekistan) between 2018 and 2023. Clinical and pathological variables included age, sex, tumor location, grade of differentiation, metastatic status, treatment characteristics, radiotherapy technique, and treatment-related toxicity. According to the predominant radiotherapy technique, patients were classified into three groups: three-dimensional conformal radiotherapy (3D-CRT; n = 41), intensity- modulated radiotherapy (IMRT; n = 32), and volumetric modulated arc therapy (VMAT; n = 28). Descriptive statistics, Pearson's chi-square test, and multivariable logistic regression analysis were performed. Results: Lower-extremity tumors represented the most common anatomical location (49.5%), and high-grade disease predominated (G3, 44.6%). Metastatic progression occurred in 20 patients (19.8%), whereas 63 patients (62.4%) remained alive without evidence of disease progression at the time of analysis. Tumor location significantly influenced radiotherapy selection (χ² = 22.48; p < 0.05). Early radiation-related skin toxicity occurred more frequently after 3D-CRT, whereas IMRT and VMAT demonstrated lower rates of treatment-related adverse events. Multivariable logistic regression analysis identified increasing age (OR = 1.03, 95% CI: 1.00–1.07, p = 0.032) and the presence of metastatic disease (OR = 20.19, 95% CI: 2.46–165.70, p = 0.005) as independent factors associated with tumor recurrence. Conclusions: Personalized radiotherapy strategies based on tumor location, biological characteristics, and treatment context were associated with favorable oncological outcomes in patients with STS. Highly conformal techniques, including IMRT and VMAT, demonstrated lower treatment-related toxicity and may represent valuable approaches for anatomically complex and biologically aggressive tumors. Increasing age and metastatic disease were independently associated with tumor recurrence.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 29 Apr 2025
Wound Complications after Soft Tissue Sarcoma Resection: A Single-centre Retrospective Analysis
Perspective · 30 Dec 2024
Myxosarcoma: A Rare and Malignant Cancer that Belongs to the Group of Soft Tissue Sarcomas
Mini review · 17 Jun 2024
Pazopanib in the Real World: Experiences with Patients in Northern California with Advanced Soft Tissue and Bone Sarcoma
Conference abstract · 27 Nov 2023
Multiple myeloma in man 32 years old with metachronous soft tissue sarcoma : A case report of multiple primary malignant tumors with successfull chemotherapy medication
More from this journal
The newest in Onkologia i Radioterapia.
Article · 30 Sep 2026
An Unusual Subcutaneous Metastasis from Anaplastic Thyroid Carcinoma: A Case Report
Article · 30 Sep 2026
Giant Renal Metastasis as a Late Recurrence of Hormone Receptor-Positive Breast Cancer with Synchronous Brain Metastases: A Case Report
Article · 30 Sep 2026
Neoadjuvant Modified FOLFIRINOX Regimen followed by Stereotactic Body Radiation Therapy (SBRT) in Non-Metastatic Pancreatic Adenocarcinoma
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalOnkologia i Radioterapia
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Otabek Agzamov”
- BylineArticles whose byline prints “Bekzod Usmanov”
- BylineArticles whose byline prints “Guli Mansurova”
- BylineArticles whose byline prints “Kamola Saidova”
- BylineArticles whose byline prints “Nargiza Karimova”
- BylineArticles whose byline prints “Ekaterina Chen”
- BylineArticles whose byline prints “Mukhayo Khayitboeva”
